

BioScience has been featured in several news, magazines and online press outlets. Click on the link to check the top publications talking about Bioscience and our brands HYAcorp and Genefill.

At IMCAS 2026, BioScience will present Smart Aesthetics: Hybrid Biostimulatory Excellence for the Face, Targeted Precision for the Body, a 90-minute symposium focused on solving today’s most persistent treatment challenges.

At IMCAS 2026, we’re putting our latest research into the spotlight – an in vitro study highlighting the biostimulatory effects of hybrid fillers, and in particular, Genefill DX.

Here’s a closer look at what our symposium at IMCAS 2026 World Congress in Paris will be covering and the key topics that our panel of global aesthetic experts will be addressing.
.webp)
Our latest in vitro study on Genefill DX, the revolutionary hybrid filler developed by BioScience, has just been published.

Join top experts on October 29 for a live webinar on advanced HA filler techniques for facial regeneration and non-surgical body contouring. Register today.

Get your summer glow with Genefill & HYAcorp dermal fillers - non-invasive aesthetic treatments for radiant skin & sculpted curves. Fast results, no downtime.

BioScience Digital Academy is a new educational initiative of BioScience. The Digital Academy strives to provide the right knowledge to medical professionals by bringing world-renowned experts for training and education on a dynamic platform.
This case presents a method for injecting dermal fillers to restore the volume of the cheekbones.

Dermal fillers have come to play an essential role in the management of aging skin, becoming part of the grooming regime for women and men.
BioScience GmbH announced the extension of the CE mark for all of the ranges of their hyaluronic acid dermal fillers: HYAcorp, Genefill and Hyaprof.


It gives us great pleasure to announce a Gold Sponsorship with ISAPS.

It gives us a great pleasure to officially announce the launch of a new product line: Hyaprof.
Subscribe to be the first to know our latest news and projects.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.